Consolidated Balance Sheet (Unaudited) - USD ($)	Jun. 30, 2016	Sep. 30, 2015
CURRENT ASSETS
Cash	$ 142,087
Prepaid Expenses	16,000
Note Receivable	12,051
Interest Receivable	2,278
Due from Former Subsidiary Employee	15,000
Total Current Assets	187,416
OTHER ASSETS
Deposits	4,200
Available for Sale Securities	80,667
Total Other Assets	84,867
TOTAL ASSETS	272,283
CURRENT LIABILITIES
Accounts Payable	289,743
Notes Payable	455,433
Bank Overdraft	0
Accrued Payroll	970,590
Accrued Payroll Taxes	43,343
Accrued Interest	364,971
Accrued Rent	15,000
Accrued Expenses	5,000
Convertible Note Payable Net of Unamortized Discount	201,759
Due to Affiliate	0
Due to Subsidiary Shareholder	0
Current portion, note payable to affiliated party	1,000
Total Current Liabilities	2,346,839
Long Term Liabilities
Convertible Note Payable Net of Unamortized Discount	102,703
Total Long Term Liabilities	102,703
Total Liabilities	2,449,542
STOCKHOLDERS EQUITY (DEFICIT)
Preferred Stock ($.0001 par value) 20,000,000 shares authorized; 20,000,000 shares authorized; 2063821 issues and outstanding as of September 30 2015 and June 30, 2016	207
Series AA Preferred ($0.0001 par value) 100,000 shares authorized 94,852 issued and outstanding as of September 30, 2015 and June 30, 2016	9
Series AAA Preferred ($0.0001 par value) 1,000,000 shares authorized 40,000 shares issued and outstanding as of September 30, 2015 and June 30, 2016	4
Series B Preferred Shares ($.0001 par value) 2,000,000 shares authorized; 725,409 issued and outstanding as of June 30, 2016 and September 30,2015 respectively	73
Common Stock ($.0001 par value) 5,000,000,000 shares authorized and 4,232,931,345 issued and outstanding as of September 30, 2015, 8,000,000,000 shares authorized and 5,746,386,628 shares issued and outstanding as of June 30, 2016	574,636
Non Voting Convertible Preferred Stock ($1 Par value) 200,000 shares authorized; 0 shares issued and outstanding as of September 30, 2015 and June 30, 2016	0
Additional Paid in capital	34,187,995
Contributed Capital	509,355
Retained Earnings (Deficit)	(37,516,099)
Accumulated Other Comprehensive Income (Loss)	(114,333)
Total Stockholders' Equity (Deficit) Biomatrix Scientific Group, Inc.	(2,358,153)
Noncontrolling Interest in subsidiary	180,894
Total Stockholders' Equity	(2,177,259)
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)	$ 272,283
Restated
CURRENT ASSETS
Cash		$ 76,355
Prepaid Expenses		25,000
Note Receivable		12,051
Interest Receivable		1,381
Total Current Assets		114,787
OTHER ASSETS
Deposits		4,200
Available for Sale Securities		159,720
Total Other Assets		163,920
TOTAL ASSETS		278,707
CURRENT LIABILITIES
Accounts Payable		167,977
Notes Payable		400,336
Bank Overdraft		0
Accrued Payroll		738,095
Accrued Payroll Taxes		44,485
Accrued Interest		324,750
Accrued Rent		10,000
Accrued Expenses		5,000
Convertible Note Payable Net of Unamortized Discount		231,507
Due to Affiliate		0
Due to Subsidiary Shareholder		0
Current portion, note payable to affiliated party		1,000
Total Current Liabilities		1,923,150
Long Term Liabilities
Convertible Note Payable Net of Unamortized Discount		0
Total Long Term Liabilities		0
Total Liabilities		1,923,150
STOCKHOLDERS EQUITY (DEFICIT)
Preferred Stock ($.0001 par value) 20,000,000 shares authorized; 20,000,000 shares authorized; 2063821 issues and outstanding as of September 30 2015 and June 30, 2016		207
Series AA Preferred ($0.0001 par value) 100,000 shares authorized 94,852 issued and outstanding as of September 30, 2015 and June 30, 2016		9
Series AAA Preferred ($0.0001 par value) 1,000,000 shares authorized 40,000 shares issued and outstanding as of September 30, 2015 and June 30, 2016		4
Series B Preferred Shares ($.0001 par value) 2,000,000 shares authorized; 725,409 issued and outstanding as of June 30, 2016 and September 30,2015 respectively		73
Common Stock ($.0001 par value) 5,000,000,000 shares authorized and 4,232,931,345 issued and outstanding as of September 30, 2015, 8,000,000,000 shares authorized and 5,746,386,628 shares issued and outstanding as of June 30, 2016		423,292
Non Voting Convertible Preferred Stock ($1 Par value) 200,000 shares authorized; 0 shares issued and outstanding as of September 30, 2015 and June 30, 2016		0
Additional Paid in capital		29,004,809
Contributed Capital		509,355
Retained Earnings (Deficit)		(31,628,963)
Accumulated Other Comprehensive Income (Loss)		(35,280)
Total Stockholders' Equity (Deficit) Biomatrix Scientific Group, Inc.		(1,726,494)
Noncontrolling Interest in subsidiary		82,050
Total Stockholders' Equity		(1,644,444)
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)		$ 278,707